A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization
Authors
Keywords
HER2, protein-protein interaction, breast cancer, peptidomimetic, dual inhibitor
Journal
Oncotarget
Volume 8, Issue 43, Pages -
Publisher
Impact Journals, LLC
Online
2017-07-06
DOI
10.18632/oncotarget.19013

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.